A. E. EŞKAZAN Et Al. , "Efficacy and Safety of Imatinib Treatment in Elderly Patients With Chronic Myeloid Leukemia: Real-Life Data and a Single-Center Experience," CLINICAL LYMPHOMA MYELOMA & LEUKEMIA , vol.21, no.8, pp.549-557, 2021
EŞKAZAN, A. E. Et Al. 2021. Efficacy and Safety of Imatinib Treatment in Elderly Patients With Chronic Myeloid Leukemia: Real-Life Data and a Single-Center Experience. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA , vol.21, no.8 , 549-557.
EŞKAZAN, A. E., Ozmen, D., ÖZTAŞ, M., Bektas, F., Bayraktar, E. A., Sadri, S., ... Keskin, D.(2021). Efficacy and Safety of Imatinib Treatment in Elderly Patients With Chronic Myeloid Leukemia: Real-Life Data and a Single-Center Experience. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA , vol.21, no.8, 549-557.
EŞKAZAN, Ahmet Et Al. "Efficacy and Safety of Imatinib Treatment in Elderly Patients With Chronic Myeloid Leukemia: Real-Life Data and a Single-Center Experience," CLINICAL LYMPHOMA MYELOMA & LEUKEMIA , vol.21, no.8, 549-557, 2021
EŞKAZAN, Ahmet E. Et Al. "Efficacy and Safety of Imatinib Treatment in Elderly Patients With Chronic Myeloid Leukemia: Real-Life Data and a Single-Center Experience." CLINICAL LYMPHOMA MYELOMA & LEUKEMIA , vol.21, no.8, pp.549-557, 2021
EŞKAZAN, A. E. Et Al. (2021) . "Efficacy and Safety of Imatinib Treatment in Elderly Patients With Chronic Myeloid Leukemia: Real-Life Data and a Single-Center Experience." CLINICAL LYMPHOMA MYELOMA & LEUKEMIA , vol.21, no.8, pp.549-557.
@article{article, author={Ahmet Emre EŞKAZAN Et Al. }, title={Efficacy and Safety of Imatinib Treatment in Elderly Patients With Chronic Myeloid Leukemia: Real-Life Data and a Single-Center Experience}, journal={CLINICAL LYMPHOMA MYELOMA & LEUKEMIA}, year=2021, pages={549-557} }